Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$122,487
in 1 filing, $122K under 10b5-1 plans

Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adams Kendra −$122K Chief Financial Officer sold 12% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-14 Boyle Scott N Chief Business Officer Option exercise +20,950 306,070
2026-02-14 Boyle Scott N Chief Business Officer Shares withheld for taxes −7,269 $1.89 $14K 298,801
2026-02-13 Boyle Scott N Chief Business Officer Grant or award +200,000 307,805
2026-02-13 Boyle Scott N Chief Business Officer Option exercise +5,000 307,805
2026-02-13 Boyle Scott N Chief Business Officer Shares withheld for taxes −1,735 $1.89 $3K 306,070
2025-02-18 Boyle Scott N Chief Business Officer Sale 10b5-1 −669 $3.15 $2K 107,805
2025-02-14 Boyle Scott N Chief Business Officer Grant or award 10b5-1 +56,500 111,332
2025-02-14 Boyle Scott N Chief Business Officer Sale 10b5-1 −490 $3.15 $2K 110,842
2025-02-14 Boyle Scott N Chief Business Officer Shares withheld for taxes 10b5-1 −2,368 $3.18 $8K 108,474
2025-02-14 Boyle Scott N Chief Business Officer Grant or award · Stock Option (Right to Buy) 10b5-1 +84,700 84,700
2025-02-13 Boyle Scott N Chief Business Officer Shares withheld for taxes 10b5-1 −1,735 $3.20 $6K 54,832
2024-11-07 Boyle Scott N Chief Business Officer Option exercise +3,750 57,669
2024-11-07 Boyle Scott N Chief Business Officer Shares withheld for taxes −1,102 $6.04 $7K 56,567
2024-11-07 Boyle Scott N Chief Business Officer Option exercise · Performance Restricted Stock Units −3,750 10,500
2024-09-16 Boyle Scott N Chief Business Officer Option exercise +2,250 54,580
2024-09-16 Boyle Scott N Chief Business Officer Shares withheld for taxes −661 $6.36 $4K 53,919
2024-09-16 Boyle Scott N Chief Business Officer Option exercise · Performance Restricted Stock Units −2,250 14,250
2024-03-07 Boyle Scott N Chief Business Officer Returned to the company · Stock Option (Right to Buy) −115,000 0
2024-03-07 Boyle Scott N Chief Business Officer Grant or award · Stock Option (Right to Buy) +115,000 115,000
2024-02-14 Boyle Scott N Chief Business Officer Grant or award +27,300 52,330

Page 1 of 2 · 34 trades